Article Commentary: Opioid Discontinuation as An Institutional Mandate: Questions and Answers on Why We Wrote to the Centers for Disease Control and Prevention

Abstract

On March 6, 2019, a self-designated committee sent a public letter to the Centers for Disease Control and Prevention (CDC) urging the agency to address the widespread misapplication of its 2016 guideline on prescribing opioids. Three hundred and eighteen health care professionals, and three former Directors of the White House Office of National Drug Control Policy (Drug Czars) signed the letter, as did the parent organization for Substance Abuse Journal, the Association for Multidisciplinary Education and Research on Substance use and Addiction. The letter reflected concern about a wide range of initiatives and policies by payers, quality metric agencies, health care organizations, and other regulators enforced to strongly incentivize or mandate forced opioid dose reductions on long-term opioid recipients who were otherwise stable. In April of 2019, both the United States Food and Drug Administration and the CDC's Director issued statements that could help to reduce ongoing harms resulting from such forced reductions, provided they are taken seriously. This commentary explains the rationale for the original letter, and the optimum course of action now that the CDC has responded.

Keywords

Opioids pain policy quality measurement

Get full access to this article

View all access options for this article.

References

Dowell

, Haegerich

, Chou

. CDC guideline for prescribing opioids for chronic pain—United States, 2016. MMWR Recomm Rep. 2016;65(1):1–49.

Hoffmann

, Goodnough

. Good news: opioid prescribing fell. The bad? Pain patients suffer, doctors say. New York Times. March 6, 2019. https://www.nytimes.com/2019/03/06/health/opioids-pain-cdc-guidelines.html. Accessed April 14, 2019.

Llorente

. As doctors taper or end opioid prescriptions, many patients driven to despair, suicide. 2018. https://www.foxnews.com/health/as-opioids-become-taboo-doctors-taper-down-or-abandon-pain-patients-driving-many-to-suicide. Accessed March 17, 2019.

Hawryluk

. Opioid crisis: pain patients pushed to the brink. Bend Bulletin. June 2, 2017. http://www.bendbulletin.com/topics/5342867-151/opioid-crisis-pain-patients-pushed-to-the-brink. Accessed August 28, 2017.

Kroenke

, Alford

, Argoff

, . Challenges with implementing the centers for disease control and prevention opioid guideline: a consensus panel report. Pain Med. 2019;20(4):724–735.

Darnall

, Juurlink

, Kerns

, . International stakeholder community of pain experts and leaders call for an urgent action on forced opioid tapering. Pain Med. 2018;20(3):429–433.

Human Rights Watch. “Not Allowed to Be Compassionate”: Chronic Pain, the Overdose Crisis, and Unintended Harms in the US. Washington, DC; December 18, 2018. https://www.hrw.org/sites/default/files/report_pdf/hhr1218_web.pdf. Accessed March 9, 2019.

Redfield

. Personal Correspondence from Director of the Centers for Disease Control and Prevention. Atlanta, GA; April 10, 2019. http://bit.ly/2P9fpx7. Accessed April 14, 2019.

United States Goverment Accountability Office. Prescription Opioids: Medicare Should Expand Oversight Efforts to Reduce the Risk of Harm. Washington, DC: United States Goverment Accountability Office; January 17, 2018. https://www.gao.gov/assets/690/689438.pdf. Accessed April 14, 2019.

10.

National Committee for Quality Assurance. NCQA Updates Quality Measures for HEDIS 2018. Washington, DC: National Committee for Quality Assurance; July 11, 2017. https://www.ncqa.org/news/ncqa-updates-quality-measures-for-hedis-2018/. Accessed April 14, 2019.

11.

Dunn

, Saunders

, Rutter

, . Opioid prescriptions for chronic pain and overdose: a cohort study. Ann Intern Med. 2010;152(2):85–92.

12.

Bohnert

ASB

, Valenstein

, Bair

, . Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA 2011;305(13):1315–1321.

13.

Glanz

, Narwaney

, Mueller

, . Prediction model for two-year risk of opioid overdose among patients prescribed chronic opioid therapy. J Gen Intern Med. 2018;33(10):1646–1653.

14.

Zedler

, Xie

, Wang

, . Risk factors for serious prescription opioid-related toxicity or overdose among Veterans Health Administration patients. Pain Med. 2014;15(11):1911–1929.

15.

Oliva

, Bowe

, Tavakoli

, . Development and applications of the Veterans Health Administration's Stratification Tool for Opioid Risk Mitigation (STORM) to improve opioid safety and prevent overdose and suicide. Psychol Serv. 2017;14(1):34–49.

16.

Frank

, Lovejoy

, Becker

, . Patient outcomes in dose reduction or discontinuation of long-term opioid therapy: a systematic review. Ann Intern Med. 2017;167(3):181–191.

17.

Vergamo

. Even More Doctors Are Cutting Back On Opioid Painkillers. May 2, 2018. https://www.buzzfeednews.com/article/danvergano/opioid-prescriptions-survey-sermo. Accessed November 15, 2018.

18.

Cigna. Cigna's Partnership with Physicians Successfully Reduces Opioid Use by 25 Percent—One Year Ahead of Goal. Bloomfield, CT; March 28, 2018. https://www.cigna.com/newsroom/news-releases/2018/cignas-partnership-with-physicians-successfully-reduces-opioid-use-by-25-percent-one-year-ahead-of-goal. Accessed June 13, 2018.

19.

Tilburt

. Addressing dual agency: getting specific about the expectations of professionalism. Am J Bioeth. 2014;14(9):29–36.

20.

United States Food and Drug Administration. FDA identifies harm reported from sudden discontinuation of opioid pain medicines and requires label changes to guide prescribers on gradual, individualized tapering. Washington, DC; April 9, 2019. https://www.fda.gov/Drugs/DrugSafety/ucm635038.htm. Accessed April 14, 2019.

21.

Baker

. History of The Joint Commission's Pain Standards: lessons for today's prescription opioid epidemic. JAMA. 2017;317(11):1117–1118.

22.

National Committee for Quality Assurance. Proposed Changes to Existing Measure for HEDIS®1 2020: Use of Opioids at High Dosage (UOD). Washington, DC: National Committee for Quality Assurance; February 12, 2019. https://www.ncqa.org/wp-content/uploads/2019/02/20190208_17_UOD.pdf. Accessed April 14, 2019.